Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

about

Sex Hormones in Acquired Immunity and Autoimmune Disease Calcium/Calmodulin Kinase IV Controls the Function of Both T Cells and Kidney Resident Cells The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus

P2860

Q58583865-90A3713A-A451-4C36-B45C-0246999A27D8 Q58592635-9C33B06C-85D2-4371-9CF0-8183739561DC Q58789362-8B590FEA-E67C-4D49-91C9-940ADE0B391C

P2860

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

Item

http://www.wikidata.org/entity/Q55096330

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@en

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@nl

type

Item

label

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@en

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@nl

prefLabel

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@en

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@nl

P1476

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

@en

P2093

George C Tsokos

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Immune homeostasis enforced by co-localized effector and regulatory T cells

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

Regulatory T cells: mechanisms of differentiation and function

Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology.

P304

786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FIMMU.2018.00786

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masayuki Mizui

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755456

http://www.w3.org/2001/XMLSchema#string

P921

systemic lupus erythematosus

peptide

lymphocyte subsets

hemic and immune systems

Achyolli

P932

5932391

http://www.w3.org/2001/XMLSchema#string

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

about

P2860

P2860

Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932